Literature DB >> 23376188

How conformational changes can affect catalysis, inhibition and drug resistance of enzymes with induced-fit binding mechanism such as the HIV-1 protease.

Thomas R Weikl1, Bahram Hemmateenejad.   

Abstract

A central question is how the conformational changes of proteins affect their function and the inhibition of this function by drug molecules. Many enzymes change from an open to a closed conformation upon binding of substrate or inhibitor molecules. These conformational changes have been suggested to follow an induced-fit mechanism in which the molecules first bind in the open conformation in those cases where binding in the closed conformation appears to be sterically obstructed such as for the HIV-1 protease. In this article, we present a general model for the catalysis and inhibition of enzymes with induced-fit binding mechanism. We derive general expressions that specify how the overall catalytic rate of the enzymes depends on the rates for binding, for the conformational changes, and for the chemical reaction. Based on these expressions, we analyze the effect of mutations that mainly shift the conformational equilibrium on catalysis and inhibition. If the overall catalytic rate is limited by product unbinding, we find that mutations that destabilize the closed conformation relative to the open conformation increase the catalytic rate in the presence of inhibitors by a factor exp(ΔΔGC/RT) where ΔΔGC is the mutation-induced shift of the free-energy difference between the conformations. This increase in the catalytic rate due to changes in the conformational equilibrium is independent of the inhibitor molecule and, thus, may help to understand how non-active-site mutations can contribute to the multi-drug-resistance that has been observed for the HIV-1 protease. A comparison to experimental data for the non-active-site mutation L90M of the HIV-1 protease indicates that the mutation slightly destabilizes the closed conformation of the enzyme. This article is part of a Special Issue entitled: The emerging dynamic view of proteins: Protein plasticity in allostery, evolution and self-assembly.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376188     DOI: 10.1016/j.bbapap.2013.01.027

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Exploring the potential impact of an expanded genetic code on protein function.

Authors:  Han Xiao; Fariborz Nasertorabi; Sei-Hyun Choi; Gye Won Han; Sean A Reed; Raymond C Stevens; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

Review 2.  Conformational selection in protein binding and function.

Authors:  Thomas R Weikl; Fabian Paul
Journal:  Protein Sci       Date:  2014-09-06       Impact factor: 6.725

3.  Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition.

Authors:  Sangwook Wu; Xuejie Chen; Da-Yun Jin; Darrel W Stafford; Lee G Pedersen; Jian-Ke Tie
Journal:  Blood       Date:  2018-05-09       Impact factor: 22.113

4.  Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis.

Authors:  Carlos Mata-Munguía; Martha Escoto-Delgadillo; Blanca Torres-Mendoza; Mario Flores-Soto; Mildred Vázquez-Torres; Francisco Gálvez-Gastelum; Arturo Viniegra-Osorio; Marcelo Castillero-Manzano; Eduardo Vázquez-Valls
Journal:  BMC Bioinformatics       Date:  2014-03-15       Impact factor: 3.169

5.  Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch.

Authors:  Simeon Eche; Ajit Kumar; Nelson Sonela; Michelle L Gordon
Journal:  Biomolecules       Date:  2021-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.